🇺🇸 Prostaglandin F2alpha in United States

7 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 7

Most-reported reactions

1. Caesarean Section — 1 report (14.29%)
2. Maternal Exposure During Pregnancy — 1 report (14.29%)
3. Post Procedural Haemorrhage — 1 report (14.29%)
4. Procedural Haemorrhage — 1 report (14.29%)
5. Retained Placenta Or Membranes — 1 report (14.29%)
6. Uterine Haemorrhage — 1 report (14.29%)
7. Uterine Hypotonus — 1 report (14.29%)

Source database →

Frequently asked questions

Is Prostaglandin F2alpha approved in United States?

Prostaglandin F2alpha does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Prostaglandin F2alpha in United States?

Danish Headache Center is the originator. The local marketing authorisation holder may differ — check the official source linked above.